Enzon Pharmaceuticals, Inc. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €0.00
    Gross profit
    €0.00
    SG&A expenses
    €1.72M
    R&D expenses
    €0.00
    EBITDA
    -€1.72M
    D&A
    €1.45M
    EBIT
    -€2.77M
    Interest expenses
    €0.00
    EBT
    -€872.75K
    Tax expenses
    €274.83K
    Net income
    -€1.15M

    Cash flow statement

    Net deferred tax
    €270.53K
    Non-cash items
    €311.88K
    Changes in working capital
    €99.94K
    Operating cash flow
    -€568.62K
    Capex
    €0.00
    Other investing cash flow
    €0.00
    Net investing cash flow
    €0.00
    Total cash dividends paid
    -€1.10M
    Issuance of common stock
    €0.00
    Debt repayment
    €0.00
    Other financing cash flow
    €0.00
    Net financing cash flow
    -€1.10M
    Foreign exchange effects
    €0.00
    Net change in cash
    -€1.67M
    Cash at end of period
    €38.16M
    Free cash flow
    -€568.62K

    Balance sheet

    Cash and cash equivalents
    €38.16M
    Cash and short-term investments
    €38.16M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €382.53K
    Total current assets
    €38.54M
    Property, plant & equipment
    €0.00
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €0.00
    Total non-current assets
    €36.19K
    Total assets
    €38.58M
    Accounts payable
    €285.17K
    Short-term debt
    €0.00
    Other current liabilities
    €406.65K
    Total current liabilities
    €691.82K
    Long-term debt
    €0.00
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €37.52M
    Total non-current liabilities
    €37.52M
    Total liabilities
    €38.21M
    Common stock
    €639.27K
    Retained earnings
    -€61.52M
    Other equity
    €0.00
    Total equity
    €372.19K
    Total liabilities and shareholders' equity
    €38.58M

    Company information

    Market capitalization
    €7.38M
    Employees
    0
    Enterprise Value
    -€38.70M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -308.3% Much worse than peer group: -143.3%
    ROA
    -3.0% Much better than peer group: -601.5%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -7.7%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    €0.00

    Notifications